| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
3.705 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
OSBPL6 |
OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 |
3.705 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
ASB6 |
ASB6: Ankyrin repeat and SOCS box protein 6 |
3.705 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
ASB12 |
ASB12: Ankyrin repeat and SOCS box protein 12 |
3.705 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
RASGRF1 |
RASGRF1, CDC25: Guanine nucleotide-releasing protein |
3.705 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
OSBPL6 |
OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 |
3.705 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
IL22RA2 |
IL22RA2, UNQ5793/PRO19598/PRO19822: Interleukin-22 receptor alpha-2 chain precur |
3.705 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
NRG4 |
NRG4: Pro-neuregulin-4, membrane-bound isoform |
3.705 |
Evidence |
|
| RFC2 |
RFC2: Replication factor C subunit 2 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
3.705 |
Evidence |
|
| RPA3 |
RPA3, REPA3, RPA14: Replication protein A 14 kDa subunit |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
3.705 |
Evidence |
O
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
FOXM1 |
FOXM1, FKHL16, HFH11, MPP2, WIN: Forkhead box protein M1 |
3.705 |
Evidence |
|
| PML |
PML, MYL, RNF71, TRIM19: Probable transcription factor PML |
UBE2B |
UBE2B, RAD6B: Ubiquitin-conjugating enzyme E2 B |
3.705 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
3.705 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
CLEC4C |
CLEC4C, BDCA2, UNQ9361/PRO34150, CLECSF11, CLECSF7, DLEC, HECL: C-type lectin do |
3.705 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
NFAM1 |
NFAM1, CNAIP: NFAT activation molecule 1 precursor |
3.705 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RASGRF2 |
RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) |
3.705 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
ASB6 |
ASB6: Ankyrin repeat and SOCS box protein 6 |
3.705 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
ARHGEF1 |
ARHGEF1: Rho guanine nucleotide exchange factor 1 |
3.705 |
Evidence |
|
| XPA |
XPA, XPAC: DNA-repair protein complementing XP-A cells |
RPA3 |
RPA3, REPA3, RPA14: Replication protein A 14 kDa subunit |
3.705 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
SIGLEC6 |
IPI00171897 |
3.705 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
ROBO1 |
IPI00418122 |
3.705 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SIRPD |
IPI00374887 |
3.705 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TSPAN18 |
TSPAN18, UNQ3042/PRO9858: Tetraspanin-18 |
3.705 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CLEC14A |
CLEC14A, C14orf27, UNQ236/PRO269, EGFR5: C-type lectin domain family 14 member A |
3.705 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TPTE |
TPTE: Putative tyrosine-protein phosphatase TPTE |
3.705 |
Evidence |
|